Probity Advisors, Inc. Moderna, Inc. Transaction History
Probity Advisors, Inc.
- $588 Million
- Q3 2025
A detailed history of Probity Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 12,944 shares of MRNA stock, worth $322,435. This represents 0.06% of its overall portfolio holdings.
Number of Shares
12,944
Previous 14,892
13.08%
Holding current value
$322,435
Previous $410,000
18.54%
% of portfolio
0.06%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
857Shares Held
266MCall Options Held
28.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.04 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$637 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$544 Million0.44% of portfolio
-
State Street Corp Boston, MA17.3MShares$430 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$221 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.74B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...